上海博研生物工程研究中心為您現(xiàn)貨提供*的產(chǎn)品與服務(wù)，本中心產(chǎn)品齊全，保證實驗的有效性，提供，是您科研實驗產(chǎn)品的一站式平臺，咨詢。！

產(chǎn)品名稱：Anti-H1N1 Matrix Protein 2抗體,A型流感病毒H1N1-M2蛋白抗體供應(yīng)商
中文名稱：A型流感病毒H1N1-M2蛋白抗體
英文名稱：Anti-H1N1 Matrix Protein 2
產(chǎn)品編號：BYK-0422R
產(chǎn)品別名：Influenza A virus （A/swine/Iowa/1/1986）; H1N1 Matrix Protein-2; Influenza A bp1 .

本公司另供應(yīng)“A型流感病毒H1N1-M2蛋白抗體”的標(biāo)記有：Alexa Fluor 350 Alexa Fluor 488 Alexa Fluor 555 Alexa Fluor 647 AP APC Biotin Cy3 Cy5 Cy5.5 Cy7 FITC Gold HRP PE PE-Cy3 PE-CY5 PE-CY5.5 PE-CY7 RBITC.
產(chǎn)品規(guī)格：100ug/200ug
產(chǎn)品濃度： 1mg/1ml
抗體來源：兔源、鼠源、山羊
克 ?。簡慰寺】贵w、多克隆抗體
抗體類型：一抗
性 狀： 凍干粉或液體
保存條件：Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

Anti-H1N1 Matrix Protein 2抗體,A型流感病毒H1N1-M2蛋白抗體供應(yīng)商技術(shù)說明，產(chǎn)品*，由于篇幅原因，更多信息請：

Anti-CollagenⅤ（Collagen Type Ⅴ）  抗Ⅴ型膠原抗體
Anti-Collagen Ⅹ（Collagen type Ⅹ）  抗Ⅹ型膠原抗體
Anti-Contactin-6/mNB-3（Neural recognition molecule NB-3）  NB-3神經(jīng)粘附蛋白抗體
Anti-CLDN1  緊密連接蛋白1抗體
Anti-CLDN5（Claudin 5）  緊密連接蛋白5抗體
Anti-CLDN1（Claudin 1）  緊密連接蛋白1抗體（C端）
Anti-COX-1 （Cyclooxygenase-1;Prostaglandin-endoperoxide synthase-1）  前列腺素氧化環(huán)化酶1抗體
Anti-CDX2（cau-dal-related homeobox transcription factor 2）  尾型同源盒轉(zhuǎn)錄因子2抗體
Anti-COX2/Cyclooxygenase 2  前列腺素氧化環(huán)化酶2抗體
Anti-COX4I1（cytochrome c oxidase subunit IV isoform 1）  *氧化酶IV亞型1抗體
Anti-C-PC（c-phycocyanin ）  C-藻藍素/藻藍蛋白抗體
Anti-C-Peptide（C-PEP）  C-肽
Anti-CPT1A（Carnitine palmitoyl transferase 1A）  抗肉毒堿棕櫚?；D(zhuǎn)移酶1A抗體
Anti-Collagen Ⅲ（Collagen type Ⅲ）  抗Ⅲ型膠原抗體
Anti-Collagen Ⅲ（Collagen type Ⅲ）  抗Ⅲ型膠原抗體
Anti-Collagen Ⅳ（Collagen type Ⅳ）  抗IV型膠原抗體
Anti-Collagen Ⅵ（Collagen type Ⅵ）  抗Ⅵ型膠原抗體
Anti-Collagen Ⅶ（Collagen Type Ⅶ）  抗Ⅶ膠原抗體（Ⅶ型膠原）抗體

Anti-H1N1 Matrix Protein 2抗體,A型流感病毒H1N1-M2蛋白抗體供應(yīng)商產(chǎn)品介紹：

Influenza A virus is a major public health threat. Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals; however it is in birds that all subtypes can be found. These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin （HA） and neuraminidase （NA） subtypes. During 1997, an H5N1 avian influenza virus was determined to be the cause of death in 6 of 18 infected patients in Hong Kong. There was some evidence of human to human spread of this virus, but it is thought that the transmission efficiency was fairly low. HA interacts with cell surface proteins containing oligosaccharides with terminal sialyl residues. Virus isolated from a human infected with the H5N1 strain in 1997 could bind to oligosaccharides from human as well as avian sources, indicating its species jumping ability.